MAR 16, 2020 9:54 PM PDT

Critical Interleukin Leads to Drug Discovery

WRITTEN BY: Nouran Amin

The immune molecule interleukin-2 (IL-2) is a growth factor that stimulates the immune system to produce T-cells. Their powerful effects have encouraged researchers to harness them for therpeutic purposes.

"IL-2 can act as either a throttle or a brake on the immune response in different contexts," said Nikolaos Sgourakis, assistant professor of chemistry and biochemistry at UC Santa Cruz. "Our investigation used detailed biophysical methods to show how it does this."

Now, a study published in the Proceedings of the National Academy of Sciences discusses how nuclear magnetic resonance spectroscopy (NMR) was used to observe the structure of IL-2.

"We can use this information to tweak the balance, depending on what we want to achieve in a clinical setting," Sgourakis said. "To target regulatory T cells, we would want to stabilize the minor conformation, and to target effector T cells, we would want to stabilize the major conformation."

Learn more about interleukins:

"We have now come one step closer to a detailed understanding of how the IL-2 cytokine works," says visiting scientists and first author, Viviane De Paula. "It is the first time that anyone has managed to observe a transient state of IL-2 directly. With the use of NMR, we were able to describe the structure, dynamics, and function of IL-2 in its two conformations."

How does the study advance drug discovery? Well, for one, researchers discuss the numerous possibilities for drug development that can stabilize IL-2 for therapeutic applications.

"The details of the mechanism we present offer a direct blueprint for drug discovery," said corresponding author Christopher Garcia. "Every drug company wants to know how to engineer this cytokine, and this paper provides some of the first really bona fide structural clarity on the fascinating topic of IL-2 dynamics."

Source: Science Daily

About the Author
Master's (MA/MS/Other)
Nouran is a scientist, educator, and life-long learner with a passion for making science more communicable. When not busy in the lab isolating blood macrophages, she enjoys writing on various STEM topics.
You May Also Like
DEC 19, 2022
Cancer
TIL Therapy for Advanced Melanoma Extends Survival Over Ipilimumab
TIL Therapy for Advanced Melanoma Extends Survival Over Ipilimumab
Immune checkpoint inhibitors (ICIs) have become a treatment option for many patients with advanced melanoma.  Still ...
JAN 03, 2023
Health & Medicine
The World's Deadliest Insect VS. mRNA Vaccines
The World's Deadliest Insect VS. mRNA Vaccines
German company BioNTech has announced their "aim to develop the first mRNA-based vaccine for malaria prevention." As par ...
JAN 05, 2023
Health & Medicine
A noninvasive sleep sensor that could prevent opioid overdose in recovering patients
A noninvasive sleep sensor that could prevent opioid overdose in recovering patients
Opioid Use Disorder (OUD) is a chronic condition of opioid use that results in significant distress, dependence, relapse ...
JAN 08, 2023
Cannabis Sciences
Reefer Before Root Canals? 52% of Dentists Report Patients Coming to Dental Appointments High
Reefer Before Root Canals? 52% of Dentists Report Patients Coming to Dental Appointments High
A recent survey by the American Dental Association (ADA) found that about 52% of dentists reported increased rates of pa ...
JAN 13, 2023
Drug Discovery & Development
Developing the First and Only Peptide-Formulated Neuromodulator for Wrinkles
Developing the First and Only Peptide-Formulated Neuromodulator for Wrinkles
In a wrinkle-reduction market run by AbbVie’s Botox™ (active ingredient onabotulinumtoxinA), Revance was jus ...
JAN 20, 2023
Drug Discovery & Development
Nutritional Supplement May Increase Hunger in People with Eating Disorders
Nutritional Supplement May Increase Hunger in People with Eating Disorders
Uridine, a precursor to RNA available as a nutrional supplement, may be able to treat eating disorders by increasing fee ...
Loading Comments...